While numerous antiepileptic drugs have a high likelihood of producing seizure freedom in new-onset epilepsy, refractory epilepsy by definition represents that 1/3rd of all epilepsy patients who cannot be successfully treated by AEDs, either alone or in combination, a situation that has persisted over decades despite the introduction of many new AEDs. However it has been widely hypothesized that some AEDs might be more effective used in combination, such that their action together exceeds the predicted sum of their individual effects, otherwise known as "synergism." We recently published a large-scale retrospective human study that demonstrated that only a single combination of AEDs, lamotrigine (LTG) plus valproate (VPA), was significantly more effective in treating refractory epilepsy, potentially exhibiting synergism, while LTG in combination with carbamazepine (CBZ) appeared to be less effective than the sum of their parts, thus exhibiting "antagonism." In this study, we wish to translate these clinical findings to an animal model of refractory epilepsy in order to understand the cellular mechanisms. We will first rigorously determine whether the efficacy of LTG/VPA represents true pharmacodynamic synergism, or results from a pharmacokinetic interaction. We will then seek evidence for a novel hypothesis as to the failure of most AED regimens in refractory epilepsy: that many AEDs constrain the excitability of inhibitory interneurons as well as excitatory principal neurons, and that this "off-target" action promotes AED refractoriness. The potential outcome of this study will be the translation from "bedside- to-bench" of a novel clinical finding-understanding the mechanisms of which could lead to an improved approach to AED design.

Public Health Relevance

Epilepsy is one of the most common neurological diseases, affecting nearly 1% of the population, and causing significant disability in the 30% of epilepsy patients whose seizures are uncontrolled by existing medication. We recently discovered that a combination of existing antiepileptic drugs (AEDs), lamotrigine and valproate, is significantly more effective than other drug regimens. This study will examine possible mechanisms at a cellular level that account for the efficacy of this AED combination, and the inferior efficacy of many other drug regimens.

Agency
National Institute of Health (NIH)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS084020-01A1
Application #
8700703
Study Section
Acute Neural Injury and Epilepsy Study Section (ANIE)
Program Officer
Whittemore, Vicky R
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Washington
Department
Neurology
Type
Schools of Medicine
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98195